ARCHIVES

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

This article is from The Cancer Letter archive.

Vol. 35 No. 14 | April 10, 2009

Download PDF Visit The Full Archive

Related Articles

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Perifosine Increases PFS In Phase II Study

December 30, 2011

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

July 30, 2004

NIH Funding Opportunities Listed

March 13, 2009

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011